Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) EBT Margin (2024 - 2025)

Prime Medicine's EBT Margin history spans 2 years, with the latest figure at 5671.24% for Q4 2025.

  • For Q4 2025, EBT Margin fell 373464.0% year-over-year to 5671.24%; the TTM value through Dec 2025 reached 4422.24%, up 214437.0%, while the annual FY2025 figure was 4408.48%, 215813.0% up from the prior year.
  • EBT Margin reached 5671.24% in Q4 2025 per PRME's latest filing, down from 4312.82% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 1936.6% in Q4 2024 to a low of 25128.23% in Q3 2024.